James D. HamptonErica J. PetersonSamantha J. KatnerTia H. TurnerMohammad A. AlzubiJ. Chuck HarrellMikhail G. DozmorovJoseph B. McGee TurnerPam J. GigliottiVita KraskauskieneMayuri ShendeMichael O. IdowuMadhavi PuchalapalliBin HuLarisa LitovchickEriko KatsutaKazuaki TakabeNicholas P. FarrellJennifer E. Koblinski
sulfated glycosaminoglycan statusanti-cancer agentssupplementary figuresnanomedicinetriple-negative breast cancercancer researchneurologypharmacologymedical mycologybreast cancercancer treatmentbreast oncologyoncologycancer careshort-term variabilitycancer immunotherapyhealth sciencesenzyme inhibitionmedicinal research
James D. HamptonErica J. PetersonSamantha J. KatnerTia H. TurnerMohammad A. AlzubiJ. Chuck HarrellMikhail G. DozmorovJoseph B. McGee TurnerPam J. GigliottiVita KraskauskieneMayuri ShendeMichael O. IdowuMadhavi PuchalapalliBin HuLarisa LitovchickEriko KatsutaKazuaki TakabeNicholas P. FarrellJennifer E. Koblinski
tumor targetingmedicinesulfated glycosaminoglycan statusanti-cancer agentscancer biologymolecular cancertriple-negative breast cancercancer researchpharmacologymedicinal chemistrycancer treatmentbreast cancerbreast oncologyoncologypharmacotherapycellular therapydrug discoverycancer discoveryradiation oncologymedicinal research
Anil K. GorleThomas HaselhorstSamantha J. KatnerArun V. Everest‐DassJames D. HamptonErica J. PetersonJennifer E. KoblinskiEriko KatsutaKazuaki TakabeMark von ItzsteinSusan J. Berners‐PriceNicholas P. Farrell
Conformational Modulation of Iduronic Acid-Containing Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound. Implications for Development of Antimetastatic Platinum Drugs. (2020)
Conformational Modulation of Iduronic Acidcontaining Sulfated Glycosaminoglycans by a Polynuclear Platinum Compound. Implications for Development of Antimetastatic Platinum Drugs.. null (2020)